Biotech company fighting coronavirus shoots down the idea of reportedly giving US exclusive rights to vaccine

· CureVac, a biopharmaceutical based in Germany reportedly rejected a proposal by the US to purchase the exclusive rights to a coronavirus vaccine.
· The company was approached by the Trump administration to bring the company to the US, according to German newspaper Welt am Sonntag.
· A CureVac investor told the Mannheimer...